Cargando…
Targeting HGF/c-MET Axis in Pancreatic Cancer
Pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC/PC)) has been an aggressive disease that is associated with early metastases. It is characterized by dense and collagenous desmoplasia/stroma, predominantly produced by pancreatic stellate cells (PSCs). PSCs interact with cancer cells as well...
Autores principales: | Pothula, Srinivasa P., Xu, Zhihong, Goldstein, David, Pirola, Romano C., Wilson, Jeremy S., Apte, Minoti V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730415/ https://www.ncbi.nlm.nih.gov/pubmed/33271944 http://dx.doi.org/10.3390/ijms21239170 |
Ejemplares similares
-
Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2017) -
Reply letter to comments on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
por: Xu, Zhihong, et al.
Publicado: (2020) -
HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer
por: Pang, Tony C. Y., et al.
Publicado: (2021) -
Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
por: Xu, Zhihong, et al.
Publicado: (2020) -
Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer
por: Pothula, Srinivasa P, et al.
Publicado: (2016)